Overview of the regulation of the class IA PI3K/AKT pathway by SUMO

被引：26
|
作者：
Vidal, Santiago [1 ]
Bouzaher, Yanis Hichem [1 ]
El Motiam, Ahmed [1 ,2 ,3 ]
Seoane, Rocio [1 ]
Rivas, Carmen [1 ,4 ]
机构：
[1] Univ Santiago De Compostela, Ctr Invest Med Mol & Enfermedades Cronicas CIMUS, Inst Invest Sanit IDIS, Santiago De Compostela 15706, Spain
[2] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Dept Ophthalmol & Vis Sci,Sinai Hlth Syst, Toronto, ON M5G 1X5, Canada
[3] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada
[4] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada
来源：
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY | 2022年 / 132卷
关键词：
SUMO; PI3K; p85; p110; AKT; PTEN; NF-KAPPA-B; CELL-CYCLE PROGRESSION; PROTEIN-KINASE-B; E3; LIGASE; TUMOR-SUPPRESSOR; PHOSPHATIDYLINOSITOL; 3-KINASE; TYROSINE PHOSPHORYLATION; EMERGING MECHANISMS; RELA/P65; SUBUNIT; TOPORS FUNCTIONS;
D O I：
10.1016/j.semcdb.2021.10.012
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The phosphatidylinositol-3-kinase (PI3K)/AKT pathway is a major regulator of metabolism, migration, survival, proliferation, and antiviral immunity. Both an overactivation and an inhibition of the PI3K/AKT pathway are related to different pathologies. Activation of this signaling pathway is tightly controlled through a multistep process and its deregulation can be associated with aberrant post-translational modifications including SUMOylation. Here, we review the complex modulation of the PI3K/AKT pathway by SUMOylation and we discuss its putative incvolvement in human disease.
引用
收藏
页码：51 / 61
页数：11
相关论文
共 50 条
  • [41] The PI3K/AKT Pathway as a Target for Cancer Treatment
    Mayer, Ingrid A.
    Arteaga, Carlos L.
    ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 : 11 - 28
  • [42] PI3K/AKT pathway activation in bladder carcinogenesis
    Calderaro, Julien
    Rebouissou, Sandra
    de Koning, Leanne
    Masmoudi, Asma
    Herault, Aurelie
    Dubois, Thierry
    Maille, Pascale
    Soyeux, Pascale
    Sibony, Mathilde
    de la Taille, Alexandre
    Vordos, Dimitri
    Lebret, Thierry
    Radvanyi, Francois
    Allory, Yves
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (08) : 1776 - 1784
  • [43] The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
    Carnero, Amancio
    Blanco-Aparicio, Carmen
    Renner, Oliver
    Link, Wolfgang
    Leal, Juan F. M.
    CURRENT CANCER DRUG TARGETS, 2008, 8 (03) : 187 - 198
  • [44] The PI3K/Akt Pathway in Meta-Inflammation
    Acosta-Martinez, Maricedes
    Cabail, Maria Zulema
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [45] The PI3K/AKT pathway in the pathogenesis of prostate cancer
    Chen, Huixing
    Zhou, Lan
    Wu, Xiaorong
    Li, Rongbing
    Wen, Jiling
    Sha, Jianjun
    Wen, Xiaofei
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2016, 21 : 1084 - 1091
  • [46] Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy
    Cidado, Justin
    Park, Ben Ho
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2012, 17 (3-4) : 205 - 216
  • [47] Dysregulation of PI3K/Akt/PTEN Pathway in Canine Mammary Tumor
    Kim, Soo-Hyeon
    Seung, Byung-Joon
    Cho, Seung-Hee
    Lim, Ha-Young
    Bae, Min-Kyung
    Sur, Jung-Hyang
    ANIMALS, 2021, 11 (07):
  • [48] Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
    Ningni Jiang
    Qijie Dai
    Xiaorui Su
    Jianjiang Fu
    Xuancheng Feng
    Juan Peng
    Molecular Biology Reports, 2020, 47 : 4587 - 4629
  • [49] PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis
    Huang, Xiao Li
    Xu, Jin
    Zhang, Xiao Hui
    Qiu, Bo Yun
    Peng, Lan
    Zhang, Meng
    Gan, Hua Tian
    INFLAMMATION RESEARCH, 2011, 60 (08) : 727 - 734
  • [50] Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer
    Su, Hua
    Peng, Chao
    Liu, Yang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
12345